DANA MANN: Open Payments
NPI 1972995314 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,293 in 165 payments from 19 companies in 2025. Trend: 2023 $2,547 · 2024 $3,124 · 2025 $3,293
Food & beverage: $3,193Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 50 | $679 |
| Janssen Biotech, Inc. | 16 | $588 |
| E.R. Squibb & Sons, L.L.C. | 19 | $432 |
| ABBVIE INC. | 20 | $341 |
| AstraZeneca Pharmaceuticals LP | 10 | $334 |
| UCB, Inc. | 14 | $227 |
| Novartis Pharmaceuticals Corporation | 8 | $183 |
| PFIZER INC. | 10 | $144 |
| GlaxoSmithKline, LLC. | 5 | $117 |
| Aurinia Pharma U.S., Inc. | 2 | $41 |
Products named: ORENCIA, TREMFYA, KRYSTEXXA, SAPHNELO, RINVOQ, Bimzelx, SIMPONI ARIA, COSENTYX.
Industry payments across KY — which companies pay providers there.
